Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("Nevirapina")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Language

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 830

  • Page / 34
Export

Selection :

  • and

Evaluation of the Safety and Effectiveness of Nevirapine Plus Coformulated Tenofovir/Emtricitabine as First-Line Therapy in Routine Clinical PracticeVALLECILLO, Gabriel; DOMINGO, Pere; MALLOLAS, Josep et al.AIDS research and human retroviruses. 2012, Vol 28, Num 2, pp 165-170, issn 0889-2229, 6 p.Article

Intrapartum exposure to nevirapine and subsequent maternal responses to nevirapine-based antiretroviral therapyJOURDAIN, Gonzague; NGO-GIANG-HUONG, Nicole; LE COEUR, Sophie et al.The New England journal of medicine. 2004, Vol 351, Num 3, pp 229-240, issn 0028-4793, 12 p.Article

The relationship between nevirapine plasma concentrations and abnormal liver function testsALMOND, Lisa M; BOFFITO, Marta; DI PERRI, Giovanni et al.AIDS research and human retroviruses. 2004, Vol 20, Num 7, pp 716-722, issn 0889-2229, 7 p.Article

Low-Frequency K103N Strengthens the Impact of Transmitted Drug Resistance on Virologic Responses to First-Line Efavirenz or Nevirapine-Based Highly Active Antiretroviral TherapyGERETTI, Anna Maria; FOX, Zoe V; BOOTH, Clare L et al.Journal of acquired immune deficiency syndromes (1999). 2009, Vol 52, Num 5, pp 569-573, issn 1525-4135, 5 p.Conference Paper

Changes in nevirapine plasma concentrations over time and its relationship with liver enzyme elevationsGONZALEZ DE REQUENA, Daniel; JIMENEZ-NACHER, Inmaculada; SORIANO, Vincent et al.AIDS research and human retroviruses. 2005, Vol 21, Num 6, pp 555-559, issn 0889-2229, 5 p.Article

Pharmacokinetic drug interactions with nevirapineBACK, David; GIBBONS, Sara; KHOO, Saye et al.Journal of acquired immune deficiency syndromes (1999). 2003, Vol 34, pp S8-S14, issn 1525-4135, SUP1Conference Paper

Efficacy and durability of Nevirapine in antiretroviral drug naïve patientsLANGE, Joep M. A.Journal of acquired immune deficiency syndromes (1999). 2003, Vol 34, pp S40-S52, issn 1525-4135, SUP1Conference Paper

Impact of nevirapine on lipid metabolismCLOTET, Bonaventura; VAN DER VALK, Marc; NEGREDO, Eugenia et al.Journal of acquired immune deficiency syndromes (1999). 2003, Vol 34, pp S79-S84, issn 1525-4135, SUP1Conference Paper

Safety of Switching Nevirapine Twice Daily to Nevirapine Once Daily in Virologically Suppressed PatientsPODZAMCZER, Daniel; OLMO, Montserrat; FORCE, Lluis et al.Journal of acquired immune deficiency syndromes (1999). 2009, Vol 50, Num 4, pp 390-396, issn 1525-4135, 7 p.Article

Pharmacokinetic parameters of nevirapine and efavirenz in relation to antiretroviral efficacyVAN LETH, F; KAPPELHOFF, B. S; WIT, F. W et al.AIDS research and human retroviruses. 2006, Vol 22, Num 3, pp 232-239, issn 0889-2229, 8 p.Article

The Nucleoside Backbone Affects Durability of Efavirenz-or Nevirapine-Based Highly Active Antiretroviral Therapy in Antiretroviral-Naive IndividualsANNAN, Naa Torshie; NELSON, Mark; MANDALIA, Sundhiya et al.Journal of acquired immune deficiency syndromes (1999). 2009, Vol 51, Num 2, pp 140-146, issn 1525-4135, 7 p.Article

Manifestations cutanées, hépatiques et hématologiques liées à la névirapine : DRESS syndrome ? = Nevirapine rash with eosinophilia and hepatitis : DRESS syndrome?SISSOKO, D; AJANA, F; DE LA TRIBONNIERE, X et al.La Presse médicale (1983). 2000, Vol 29, Num 19, pp 1041-1042, issn 0755-4982Article

HLA-Dependent Hypersensitivity Reaction to Nevirapine in Chinese Han HIV-Infected PatientsSHICHENG GAO; GUI, Xi-En; KE LIANG et al.AIDS research and human retroviruses. 2012, Vol 28, Num 6, pp 540-543, issn 0889-2229, 4 p.Article

Comparative Outcomes of Tenofovir-Based and Zidovudine-Based Antiretroviral Therapy Regimens in Lusaka, ZambiaCHI, Benjamin H; MWANGO, Albert; STRINGER, Elizabeth M et al.Journal of acquired immune deficiency syndromes (1999). 2011, Vol 58, Num 5, pp 475-481, issn 1525-4135, 7 p.Article

Prevalence of Etravirine-Associated Mutations in Clinical Samples With Genotypic Resistance to Nevirapine and Efavirenz in Brazilian ClinicsMARTINS, Angelica N; ARRUDA, Monica B; ALEIXO, Agdemir W et al.Journal of acquired immune deficiency syndromes (1999). 2011, Vol 57, issn 1525-4135, S193-S196, SUP3Article

Patients Infected with HIV Type 1 Subtype CRF01_AE and Failing First-Line Nevirapine- and Efavirenz-Based Regimens Demonstrate Considerable Cross-Resistance to EtravirineMANOSUTHI, Weerawat; BUTLER, David M; CHANTRATITA, Wasun et al.AIDS research and human retroviruses. 2010, Vol 26, Num 6, pp 609-611, issn 0889-2229, 3 p.Article

Influence of the Composition of Water/Ethanol Mixtures on the Solubility and Recrystallization of NevirapineSTIEGER, Nicole; CAIRA, Mino R; LIEBENBERG, Wilna et al.Crystal growth & design. 2010, Vol 10, Num 9, pp 3859-3868, issn 1528-7483, 10 p.Article

Enzyme inducers reduce elimination half-life after a single dose of nevirapine in healthy womenL'HOMME, Rafaëlla F. A; DIJKEMA, Tim; VAN DER VEN, Andre J. A. M et al.Journal of acquired immune deficiency syndromes (1999). 2006, Vol 43, Num 2, pp 193-196, issn 1525-4135, 4 p.Article

Long-term safety and efficacy of nevirapine-based approaches in HIV type 1-infected patientsBONJOCH, Anna; PAREDES, Roger; CUCURULL, Josep et al.AIDS research and human retroviruses. 2006, Vol 22, Num 4, pp 321-329, issn 0889-2229, 9 p.Article

Estimating Frequencies of Minority Nevirapine-Resistant Strains in Chronically HIV-1-Infected Individuals Naïve to Nevirapine by Using Stochastic Simulations and a Mathematical ModelGADHAMSETTY, Saikrishna; DIXIT, Narendra M.Journal of virology. 2010, Vol 84, Num 19, pp 10230-10240, issn 0022-538X, 11 p.Article

Maternal toxicity with continuous nevirapine in pregnancy: Results from PACTG 1022HITTI, Jane; FRENKEL, Lisa M; GANDIA, Jorge et al.Journal of acquired immune deficiency syndromes (1999). 2004, Vol 36, Num 3, pp 772-776, issn 1525-4135, 5 p.Article

Treatment Outcomes of Recommended First-Line Antiretroviral Regimens in Resource-Limited ClinicsAMOROSO, Anthony; ETIENNE-MESUBI, Martine; EDOZIEN, Anthony et al.Journal of acquired immune deficiency syndromes (1999). 2012, Vol 60, Num 3, pp 314-320, issn 1525-4135, 7 p.Article

Nevirapine plasma concentrations are still detectable after more than 2 weeks in the majority of women receiving single-dose nevirapine : Implications for intervention studiesMURO, Eva; DROSTE, Jacqueline A. H; TER HOFSTEDE, Hadewych et al.Journal of acquired immune deficiency syndromes (1999). 2005, Vol 39, Num 4, pp 419-421, issn 1525-4135, 3 p.Article

Defining the toxicity profile of nevirapine and other antiretroviral drugsMURPHY, Robert L.Journal of acquired immune deficiency syndromes (1999). 2003, Vol 34, pp S15-S20, issn 1525-4135, SUP1Conference Paper

Tolerability and Effectiveness of First-Line Regimens Combining Nevirapine and Lamivudine Plus Zidovudine or Stavudine in CameroonLAURENT, Christian; BOURGEOIS, Anke; MPOUDI-NGOLE, Eitel et al.AIDS research and human retroviruses. 2008, Vol 24, Num 3, pp 393-399, issn 0889-2229, 7 p.Article

  • Page / 34